Creating a new rapid test for diagnosing Chagas disease
Official title: Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease
Funded at Inbios International, INC. · NIH-11086142 · Data updated 2026-11-12
This study is working on a new, quick test called Chagas Detect PlusTM to help find Chagas disease in people who might not show any symptoms, so they can get treated sooner and avoid serious health issues later on.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Inbios International, INC. NIH-funded |
| Lab location | 1 site (Seattle, UNITED STATES) |
| Project start | May 8, 2024 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $988,977 |
| NIH project number | 5R44AI184032-02 |
| Project ID | NIH-11086142 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals from regions where Chagas disease is prevalent, particularly those who may be asymptomatic but at risk of infection.
✕Less likely to help
Patients who are not at risk for Chagas disease or those who have already been diagnosed and treated may not benefit from this research.
What this research studies
This research focuses on developing an advanced rapid test called Chagas Detect PlusTM that aims to accurately diagnose Chagas disease, which is caused by the Trypanosoma cruzi parasite. The project seeks to enhance the sensitivity and specificity of the test to ensure that it can effectively identify asymptomatic individuals who may be infected. By optimizing the test's performance and preparing it for FDA clearance, the research aims to make this diagnostic tool widely available for use in both the US and globally. This could lead to earlier treatment for those infected, reducing the risk of severe health complications later on.
Why it matters
Potential benefit: If successful, this research could lead to a highly accurate and accessible test for Chagas disease, enabling early diagnosis and treatment.
How similar studies have gone: Previous research has shown success in developing rapid tests for other infectious diseases, indicating potential for this approach in Chagas disease diagnostics.
Where this research is happening
-
Inbios International, INC.
Seattle, United States Active
Researchers
- Principal investigator: Raychaudhuri, Syamal X — Inbios International, INC.
- Study coordinator: Raychaudhuri, Syamal X
Related research
Other NIH-funded projects on the same topics.
-
Next-generation Chagas Detect Plus Rapid Test for Sensitive and Specific Diagnosis
A new rapid test for Chagas disease aims to deliver fast, highly accurate results so people who might be infected can get timely care.
-
Sensitive point-of-care test for tick-borne spotted fever group rickettsioses
A fast, easy-to-use test kit is being developed to detect early signs of tick-borne spotted fever group infections so patients can get treated sooner.
-
Creating a quick at-home test for prostate cancer detection using fingerstick blood samples
This study is working on a quick and easy at-home test that helps African-American men check for high levels of a protein linked to prostate cancer using just a drop of blood from a fingerstick, making it simple to use without any fancy equipment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.